{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:14:06Z","timestamp":1762272846430,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Activated cdc42-associated kinase 1 (ACK1) is a well-known non-receptor tyrosine kinase that regulates cell proliferation and growth through activation of cellular signaling pathways, including mitogen-activated protein kinase (MAPK). However, the anti-HBV activity of ACK1 has not been elucidated. This study aimed to investigate the role of ACK1 in the HBV life cycle and the mechanism underlying the anti-HBV activity of ACK1. To examine the antiviral activity of ACK1, we established HepG2-ACK1 cells stably overexpressing ACK1. The HBV life cycle, including HBeAg\/HBsAg secretion, HBV DNA\/transcription, and enhancer activity, was analyzed in HepG2 and HepG2-ACK1 cells with HBV replication-competent HBV 1.2mer (HBV 1.2). Finally, the anti-HBV activity of ACK1 was examined in an HBV infection system. ACK1 suppressed HBV gene expression and transcription in HepG2 and HepG2-ACK1 cells. Furthermore, ACK1 inhibited HBV replication by decreasing viral enhancer activity. ACK1 exhibited its anti-HBV activity via activation of Erk1\/2, which consequently downregulated the expression of HNF4\u03b1 binding to HBV enhancers. Furthermore, hepatocyte growth factor (HGF) induced ACK1 expression at an early stage. Finally, ACK1 mediated the antiviral effect of HGF in the HBV infection system. These results indicated that ACK1 induced by HGF inhibited HBV replication at the transcriptional level by activating the MAPK-HNF signaling pathway. Our findings suggest that ACK1 is a potentially novel upstream molecule of MAPK-mediated anti-HBV activity.<\/jats:p>","DOI":"10.3389\/fmicb.2021.800935","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:33:43Z","timestamp":1640284423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatocyte Growth Factor-Dependent Antiviral Activity of Activated cdc42-Associated Kinase 1 Against Hepatitis B Virus"],"prefix":"10.3389","volume":"12","author":[{"given":"Hye Won","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Ram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyun-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Sun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Kwang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12974","DOI":"10.1128\/jvi.76.24.12974-12980.2002","article-title":"Hepatocyte nuclear factor 3b inhibits hepatitis B virus replication in vivo.","volume":"76","author":"Banks","year":"2002","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/BJ20102156","article-title":"The Cdc42\u2013associated kinase ACK1 is not autoinhibited but requires Src for activation.","volume":"435","author":"Chan","year":"2011","journal-title":"Biochem. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1128\/MCB.24.4.1799-1808.2004","article-title":"Enhancer I predominance in hepatitis B virus gene expression.","volume":"24","author":"Doitsh","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jhep.2010.07.021","article-title":"A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients.","volume":"54","author":"Fujimoto","year":"2011","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9796","DOI":"10.1073\/pnas.0603714103","article-title":"Activation of the nonreceptor protein tyrosine kinase Ack1 by multiple extracellular stimuli.","volume":"103","author":"Galisteo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1128\/JVI.67.7.3940-3950.1993","article-title":"Functional interaction of nuclear factors EF\u2013C, HNF\u20134, and RXRa with hepatitis B virus enhancer I.","volume":"67","author":"Garcia","year":"1993","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.yexcr.2007.12.017","article-title":"Dysregulation of Ack1 inhibits down\u2013regulation of the EGF receptor.","volume":"314","author":"Grovdal","year":"2008","journal-title":"Exp. Cell Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1128\/MCB.00297-06","article-title":"Mitogen\u2013activated protein kinase\u2013mediated disruption of enhancer\u2013promoter communication inhibits hepatocyte nuclear factor 4\u03b1 expression.","volume":"26","author":"Hatzis","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1128\/mcb.21.21.7320-7330.2001","article-title":"Regulatory mechanisms controlling human hepatocyte nuclear factor 4\u03b1 gene expression.","volume":"21","author":"Hatzis","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e30360","DOI":"10.1371\/journal.pone.0030360","article-title":"Transforming growth factor\u2013\u03b21 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor\u20134\u03b1 expression.","volume":"7","author":"Hong","year":"2012","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin\u20136 controls early gene expression in hepatitis B virus infection.","volume":"50","author":"H\u00f6sel","year":"2009","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host\u2013entry cofactor triggering hepatitis B virus internalization.","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1742-4658.2012.08514.x","article-title":"Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation.","volume":"279","author":"Khattar","year":"2012","journal-title":"FEBS J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/s41467-018-05782-5","article-title":"Intracellular interleukin\u201332\u03b3 mediates antiviral activity of cytokines against hepatitis B virus.","volume":"9","author":"Kim","year":"2018","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1093\/emboj\/18.18.5019","article-title":"Src kinase involved in hepatitis B virus replication.","volume":"18","author":"Klein","year":"1999","journal-title":"EMBO J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.1128\/MCB.17.11.6427","article-title":"Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling Ras.","volume":"17","author":"Klein","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"40622","DOI":"10.18632\/oncotarget.5872","article-title":"Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.","volume":"6","author":"Lei","year":"2015","journal-title":"Oncotarget"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1158\/0008-5472.CAN-11-2260","article-title":"Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway.","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1073\/pnas.87.13.5069","article-title":"Multiple liver\u2013specific factors bind to the hepatitis B virus core\/pregenomic promoter, transactivation and repression by CCAAT\/enhancer binding protein.","volume":"87","author":"Lopez-Cabrera","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"28179","DOI":"10.1074\/jbc.M114.584425","article-title":"ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.","volume":"289","author":"Mahajan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1038\/onc.2014.350","article-title":"ACK1\/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.","volume":"34","author":"Mahajan","year":"2015","journal-title":"Oncogene"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8438","DOI":"10.1073\/pnas.0700420104","article-title":"Activated Cdc42\u2013associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.","volume":"104","author":"Mahajan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1158\/0008-5472.CAN-05-1127","article-title":"Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of ACk1 in polyubiquitination of tumor suppressor Wwox.","volume":"65","author":"Mahajan","year":"2005","journal-title":"Cancer Res."},{"key":"B24","first-page":"949","article-title":"Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.","volume":"143","author":"Mars","year":"1993","journal-title":"Am. J. Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2893.2002.00381.x","article-title":"Regulatory element of hepatitis B virus transcription.","volume":"9","author":"Moolla","year":"2002","journal-title":"J. Viral Hepat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1002\/j.1460-2075.1992.tb05588.x","article-title":"Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor\/scatter factor.","volume":"11","author":"Naldini","year":"1992","journal-title":"EMBO J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA, viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hep.26379","article-title":"Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase\u2013type plasminogen activator.","volume":"58","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jgh.14986","article-title":"Antiviral activity of interferon\u2013stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter.","volume":"35","author":"Park","year":"2020","journal-title":"J. Gasrtroenterol. Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2015.09.012","article-title":"Cleaved c\u2013FLIP mediates the antiviral effect of TNF\u2013\u03b1 against hepatitis B virus by dysregulating hepatocyte nuclear factors.","volume":"64","author":"Park","year":"2016","journal-title":"J. Hepatol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection.","volume":"479","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1091\/mbc.e06-02-0142","article-title":"Activated cdc42\u2013associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.","volume":"18","author":"Shen","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.bbadis.2014.04.016","article-title":"Hepatocystin contributes to interferon\u2013mediated antiviral response to hepatitis B virus by regulating hepatocyte nuclear factor 4\u03b1.","volume":"1842","author":"Shin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.89.7.2708","article-title":"Regulation of hepatitis B virus gene expression by its two enhancers.","volume":"89","author":"Su","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1073\/pnas.041479698","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism.","volume":"98","author":"Tang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1128\/jvi.76.17.8572-8581.2002","article-title":"Mechanisms of inhibition of nuclear hormone receptor\u2013dependent hepatitis B virus replication by hepatocyte nuclear factor 3\u03b2.","volume":"76","author":"Tang","year":"2002","journal-title":"J. Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.1074\/jbc.M008795200","article-title":"The tyrosine kinase ACK1 associated with clathrin\u2013coated vesicles through a binding motif share by arrestin and other adaptors.","volume":"276","author":"Teo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1128\/JVI.06707-11","article-title":"Enhancement of hepatitis B virus replication by androgen and its receptor in mice.","volume":"86","author":"Tian","year":"2012","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection.","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"40968","DOI":"10.1074\/jbc.M010890200","article-title":"High intensity Erk signal mediates hepatocyte growth factor induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.","volume":"276","author":"Tsukada","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.23163","article-title":"Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1053\/j.gastro.2011.12.045","article-title":"Estrogen receptor \u03b1 represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4\u03b1.","volume":"142","author":"Wang","year":"2012","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"32r35","DOI":"10.1126\/scitranslmed.3001143","article-title":"Androgen receptor promotes hepatitis B virus\u2013induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.","volume":"2","author":"Wu","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B44","doi-asserted-by":"crossref","first-page":"47713","DOI":"10.1074\/jbc.M306716200","article-title":"Biochemical properties of cdc42\u2013associated tyrosine kinase ACK1.","volume":"278","author":"Yokoyama","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1128\/JVI.64.9.4281-4287.1990","article-title":"The genome of hepatitis B virus contains a second enhancer, cooperation of two elements within this enhancer is required for its function.","volume":"64","author":"Yuh","year":"1990","journal-title":"J. Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"30181","DOI":"10.1074\/jbc.M112.370312","article-title":"Mucroporin\u2013M1 inhibits hepatitis B virus replication by activating mitogen\u2013activated protein kinase (MAPK) pathway and down\u2013regulating HNF4a in vitro and in vivo.","volume":"287","author":"Zhao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6908","DOI":"10.1128\/JVI.78.13.6908-6914.2004","article-title":"Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein.","volume":"78","author":"Zheng","year":"2004","journal-title":"J. Virol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.800935\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:33:49Z","timestamp":1640284429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.800935\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":47,"alternative-id":["10.3389\/fmicb.2021.800935"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.800935","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"800935"}}